Characterization of the 1918 "Spanish" influenza virus matrix gene segment

Journal of Virology

Volumn 76, Issue 21, 2002, Pages 10717-10723

  Reid, Ann H ^a   Fanning, Thomas G ^a   Janczewski, Thomas A ^a   McCall, Sherman ^a   Taubenberger, Jeffery K ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MATRIX PROTEIN; PROTEIN M1; PROTEIN M2; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; CONSENSUS SEQUENCE; FOWL; GENE SEQUENCE; GENETIC CONSERVATION; HUMAN; INFLUENZA VIRUS; MAMMAL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENY; PRIORITY JOURNAL; PROTEIN RNA BINDING; VIRUS GENE; VIRUS PATHOGENESIS; VIRUS STRAIN;

AMANTADINE; ANTIVIRAL AGENTS; BASE SEQUENCE; DRUG RESISTANCE, VIRAL; GENES, VIRAL; HUMANS; INFLUENZA A VIRUS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SPAIN; VIRAL MATRIX PROTEINS;

EID: 0036838584     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.21.10717-10723.2002     Document Type: Article

References (60)

1. Ali, A., R. T. Avalos, E. Ponimaskin, and D. P. Nayak. 2000. Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein. J. Virol. 74:8709-8719.
2. Baez, M., P. Palese, and E. D. Kilbourne. 1980. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J. Infect. Dis. 141:362-365.
3. Basler, C. F., A. H. Reid, J. K. Dybing, T. A. Janczewski, T. G. Fanning, H. Zheng, M. Salvatore, M. L. Perdue, D. E. Swayne, A. Garcia-Sastre, P. Palese, and J. K. Taubenberger. 2001. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc. Natl. Acad. Sci. USA 98:2746-2751.
4. Bauer, C. M., L. H. Pinto, T. A. Cross, and R. A. Lamb. 1999. The influenza virus M2 ion channel protein: probing the structure of the transmembrane domain in intact cells by using engineered disulfide cross-linking. Virology 254:196-209.
5. Belshe, R., M. Smith, C. Hall, R. Betts, and A. Hay. 1988. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J. Virol. 62:1508-1512.
6. Brown, E., H. Liu, L. Kit, S. Baird, and M. Nesrallah. 2001. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc. Natl. Acad. Sci. USA 98:6883-6888.
7. Bucher, D. J., I. G. Kharitonenkov, J. A. Zakomirdin, V. B. Grigoriev, S. M. Klimenko, and J. F. Davis. 1980. Incorporation of influenza virus M-protein into liposomes. J. Virol. 36:586-590.
8. Bui, M., E. G. Wills, A. Helenius, and G. R. Whittaker. 2000. Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J. Virol. 74:1781-1786.
9. Elster, C., E. Fourest, F. Baudin, K. Larsen, S. Cusack, and R. W. Ruigrok. 1994. A small percentage of influenza virus M1 protein contains zinc but zinc does not influence in vitro M1-RNA interaction. J. Gen. Virol. 75:37-42.
10. Elster, C., K. Larsen, J. Gagnon, R. W. Ruigrok, and F. Baudin. 1997. Influenza virus M1 protein binds to RNA through its nuclear localization signal. J. Gen. Virol. 78:1589-1596.
11. Enami, M., and K. Enami. 1996. Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J. Virol. 70:6653-6657.
12. Gomez-Puertas, P., C. Albo, E. Perez-Pastrana, A. Vivo, and A. Portela. 2000. Influenza virus matrix protein is the major driving force in virus budding. J. Virol. 74:11538-11547.
13. Govorkova, E. A., A. S. Gambaryan, E. C. Claas, and Y. A. Smirnov. 2000. Amino acid changes in the hemagglutinin and matrix proteins of influenza A (H2) viruses adapted to mice. Acta Virol. 44:241-248.
14. Grambas, S., and A. J. Hay. 1992. Maturation of influenza A virus hemagglutinin-estimates of the pH encountered during transport and its regulation by the M2 protein. Virology 190:11-18.
15. Gregoriades, A., and B. Frangione. 1981. Insertion of influenza M protein into the viral lipid bilayer and localization of site of insertion. J. Virol. 40:323-328.
16. Harris, A., F. Forouhar, S. Qiu, B. Sha, and M. Luo. 2001. The crystal structure of the influenza matrix protein M1 at neutral pH: M1-M1 protein interfaces can rotate in the oligomeric structures of Ml. Virology 289:34-44.
17. Hay, A. J., N. C. Kennedy, J. J. Skehel, and G. Appleyard. 1979. The matrix protein gene determines amantadine-sensitivity of influenza viruses. J. Gen. Virol. 42:189-191.
18. Hay, A. J., A. J. Wolstenholme, J. J. Skehel, and M. H. Smith. 1985. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4:3021-3024.
19. Helenius, A. 1992. Unpacking the incoming influenza virus. Cell 69:577-578.
20. Holsinger, L. J., and R. A. Lamb. 1991. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology 183:32-43.
21. Holsinger, L. J., D. Nichani, L. H. Pinto, and R. A. Lamb. 1994. Influenza A virus M2 ion channel protein: a structure-function analysis. J. Virol. 68:1551-1563.
22. Holsinger, L. J., M. A. Shaughnessy, A. Micko, L. H. Pinto, and R. A. Lamb. 1995. Analysis of the posttranslational modifications of the influenza virus M2 protein. J. Virol. 69:1219-1225.
23. Johnson, N. P., and J. Mueller. 2002. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull. Hist. Med. 76:105-115.
24. Katz, J., X. Lu, T. Tumpey, C. Smith, M. Shaw, and K. Subbarao. 2000. Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J. Virol. 74:10807-10810.
25. Kawaoka, Y., S. Krauss, and R. G. Webster. 1989. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J. Virol. 63:4603-4608.
26. Kilbourne, E. D. 1977. Influenza pandemics in perspective. JAMA 237:1225-1228.
27. Krafft, A. E., B. W. Duncan, K. E. Bijwaard, J. K. Taubenberger, and J. H. Lichy. 1997. Optimization of the isolation and amplification of RNA from formalin-fixed, paraffin-embedded tissue: the Armed Forces Institute of Pathology Experience and Literature Review. Mol. Diagn. 2:217-230.
28. Lamb, R. A., and R. M. Krug. 2001. Orthomyxoviridae: the viruses and their replication, p. 1487-1531. In D. A. Knipe, P. M. Howley, et al. (ed.), Fields virology, 4th ed., vol. 1. Lippincott Williams and Wilkins, Philadelphia, Pa.
29. Lamb, R. A., C. J. Lai, and P. W. Choppin. 1981. Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc. Natl. Acad. Sci. USA 78:4170-4174.
30. Lamb, R. A., S. L. Zebedee, and C. D. Richardson. 1985. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40:627-633.
31. Latham, T., and J. M. Galarza. 2001. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J. Virol. 75:6154-6165.
32. Martin, K., and A. Helenius. 1991. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117-130.
33. Murphy, B., A. Buckler-White, W. London, and M. Snyder. 1989. Characterization of the M protein and nucleoprotein genes of an avian influenza A virus which are involved in host range restriction in monkeys. Vaccine 7:557-561.
34. Murti, K. G., P. S. Brown, W. J. Bean, Jr., and R. G. Webster. 1992. Composition of the helical internal components of influenza virus as revealed by immunogold labeling/electron microscopy. Virology 186:294-299.
35. Patterson, K. D., and G. F. Pyle. 1991. The geography and mortality of the 1918 influenza pandemic. Bull. Hist. Med. 65:4-21.
36. Perez, D. R., and R. O. Donis. 1998. The matrix 1 protein of influenza A virus inhibits the transcriptase activity of a model influenza reporter genome in vivo. Virology 249:52-61.
37. Pinto, L. H., L. J. Holsinger, and R. A. Lamb. 1992. Influenza virus M2 protein has ion channel activity. Cell 69:517-528.
38. Rees, P. J., and N. J. Dimmock. 1981. Electrophoretic separation of influenza virus ribonucleoproteins. J. Gen. Virol. 53:125-132.
39. Reid, A. H., T. G. Fanning, J. V. Hultin, and J. K. Taubenberger. 1999. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc. Natl. Acad. Sci. USA 96:1651-1656.
40. Reid, A. H., T. G. Fanning, T. A. Janczewski, and J. K. Taubenberger. 2000. Characterization of the 1918 "Spanish" influenza virus neuraminidase gene. Proc. Natl. Acad. Sci. USA 97:6785-6790.
41. Sha, B., and M. Luo. 1997. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein Ml. Nat. Struct. Biol. 4:239-244.
42. Smeenk, C. A., and E. G. Brown. 1994. The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J. Virol. 68:530-534.
43. Smeenk, C. A., K. E. Wright, B. F. Burns, A. J. Thaker, and E. G. Brown. 1996. Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis. Virus Res. 44:79-95.
44. Subbarao, E., M. Perkins, J. Treanor, and B. Murphy. 1992. The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect. Virus Res. 25:37-50.
45. Sugrue, R. J., R. B. Belshe, and A. J. Hay. 1990. Palmitoylation of the influenza A virus M2 protein. Virology 179:51-56.
46. Sugrue, R. J., and A. J. Hay. 1991. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 180:617-624.
47. Takeuchi, K., and R. A. Lamb. 1994. Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J. Virol. 68:911-919.
48. Taubenberger, J. K., A. H. Reid, A. E. Krafft, K. E. Bijwaard, and T. G. Fanning. 1997. Initial genetic characterization of the 1918 "Spanish" influenza virus. Science 275:1793-1796.
49. Wakefield, L., and G. Brownlee. 1989. RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Res. 17:8569-8580.
50. Wang, C., R. A. Lamb, and L. H. Pinto. 1994. Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells. Virology 205:133-140.
51. Ward, A. C. 1997. Virulence of influenza A virus for mouse lung. Virus Genes 14:187-194.
52. Winter, G., and S. Fields. 1980. Cloning of influenza cDNA into M13: the sequence of the RNA segment encoding the A/PR/8/34 matrix protein. Nucleic Acids Res. 8:1965-1974.
53. Winternitz, M. C., I. M. Wason, and F. P. McNamara. 1920. The pathology of influenza. Yale University Press, New Haven, Conn.
54. Wolbach, S. B. 1919. Comments on the pathology and bacteriology of fatal influenza cases, as observed at Camp Devens, Mass. Johns Hopkins Hosp. Bull. 30:104.
55. Yasuda, J., D. J. Bucher, and A. Ishihama. 1994. Growth control of influenza A virus by M1 protein: analysis of transfectant viruses carrying the chimeric M gene. J. Virol. 68:8141-8146.
56. Yasuda, J., T. Toyoda, M. Nakayama, and A. Ishihama. 1993. Regulatory effects of matrix protein variations on influenza virus growth. Arch. Virol. 133:283-294.
57. Ye, Z., T. Liu, D. P. Offringa, J. McInnis, and R. A. Levandowski. 1999. Association of influenza virus matrix protein with ribonucleoproteins. J. Virol. 73:7467-7473.
58. Ye, Z., D. Robinson, and R. Wagner. 1995. Nucleus -targeting domain of the matrix protein (M1) of influenza virus. J. Virol. 69:1964-1970.
59. Ye, Z. P., N. W. Baylor, and R. R. Wagner. 1989. Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J. Virol. 63:3586-3594.
60. Zvonarjev, A. Y., and Y. Z. Ghendon. 1980. Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine. J. Virol. 33:583-586.